Addition- ally the potential efficacy of pre- pro- and synbiotics in the restoration of healthy gut microbia is described in detail to provide future directions for research.Keywords Chronic kidney disease CKD  Intestinal microbiota  Uremic toxins  Lipopolysaccharides LPS  Immune deregulation  Prebiotic  ProbioticsWei Pan and Yongbo Kang have contributed equally to this work.AbbreviationsBUNBlood urea nitrogen CKDChronic kidney disease CVDCardiovascular disease DMADimethylamineESKD End-stage kidney disease GFR Glomerular filtration rate GIT Gastrointestinal tractGLP-1Glucagon-like peptide 1 GOSsGalacto-oligosaccharides IL-6Interleukin-6ISIndoxyl sulfateLPSLipopolysaccharides NKTNatural killer TPCSP-cresyl sulfatePYYPeptide YYRSResistant starch SCFAsShort-chain fatty acidsIntroductionChronic kidney disease CKD as a frequently life-threat- ening disorder that influences the structure and function of the kidney represents a typical predictor of end-stage kidney Yongbo Kang 1 Faculty of Foreign Languages and Cultures Kunming University of Science and Technology Kunming Yunnan China2 Medical Faculty Kunming University of Science and Technology Kunming Yunnan China3 Genetics and Pharmacogenomics Laboratory Kunming University of Science and Technology Kunming Yunnan Chinadisease ESKD and is badly in need of approaches for pre- vention early detection and treatment .

It is clear that inflammatory promoters including graft ischemia time baseline disease and immunosuppressive drugs may facili- tate the breakdown of the gut barrier  .Immune deregulationGut microflora as a cause of inflammationAltered gut bacteria and their products are also associ- ated with systemic inflammation given that higher lev- els of C-reactive protein pentraxin-3 proinflammatory cytokines  sTWEAK sTRAIL S100A12 man- nose-binding lectin and activated complement  were observed in ESRD patients.

Nephrol Dial Transplant 263759-761Barreto FC Barreto DV Liabeuf S et al 2009 Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.

Annu Rev Pathol Mech Dis 619-48Carrero JJ Stenvinkel P 2010 Inflammation in end-stage renal disease--What have we learned in 10 years Semin Dial 235498-509Harris K Kassis A Major G et al 2012 Is the gut microbiota a new factor contributing to obesity and its metabolic disor- ders J Obes 2012879151Chow J Tang H Mazmanian SK 2011 Pathobionts of the gastrointestinal microbiota and inflammatory disease.

Bone 79252-258Howitt MR Garrett WS 2012 A complex microworld in the gut gut microbiota and cardiovascular disease connectivity.

httpsdoi.org10.1007s11255-017-1689-5Gut microbiota and chronic kidney disease implications for novel mechanistic insights and therapeutic strategiesWei Pan1  Yongbo Kang23Received 22 June 2017  Accepted 23 August 2017  Published online 28 August 2017c Springer ScienceBusiness Media B.V. 2017Abstract The complicated communities of microbiota col- onizing the human gastrointestinal tract exert a strong func- tion in health maintenance and disease prevention.

In Proceedings of the 2010 annual data report atlas of chronic kidney disease and end-stage renal disease in the United States vol 2.

Lancet 35391671838-1842McIntyre CW Harrison LE Eldehni MT et al 2011 Circulat- ing endotoxemia a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease.

ASAIO J 52170-79Niwa T 2011 Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease experimental and clinical effects of oral sorbent AST-120.

Disorder of healthy gut micro- biota dysbiosis has been involved in the pathogenesis of a great number of diseases such as obesity  type 2 dia- betes and cardiovascular disease CVD  .

